Showing results (101-110 of 129) with videos related to
Sort By:
Pageof 13
British Journal of Clinical Pharmacology|August 1, 1981
Radioimmunoassay for trifluoperazine in human plasmaK K Midha, J W Hubbard, J K Cooper, et al.Journal of Pharmacological Methods|June 1, 1983
Development of radioimmunoassays for trifluoperazine and their application to metabolic studies of the drugK K Midha, E M Hawes, G Rauw, et al.Therapeutic Drug Monitoring|January 1, 1985
Therapeutic monitoring of chlorpromazine II: Pitfalls in whole blood analysisG McKay, J K Cooper, E M Hawes, et al.Therapeutic Drug Monitoring|January 1, 1988
An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detectionK K Midha, J K Cooper, E M Hawes, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1991
Identification of phase-I and phase-II metabolites of fluphenazine in rat bile. Intact glucuronide and sulfate conjugatesC J Jackson, J W Hubbard, G McKay, et al.Journal of Pharmaceutical Sciences|February 1, 1984
Relative bioavailability of a commercial trifluoperazine tablet formulation using a radioimmunoassay techniqueK K Midha, E D Korchinski, R M Roscoe, et al.Therapeutic Drug Monitoring|January 1, 1983
Radioimmunoassay for prochlorperazine in human plasmaK K Midha, E M Hawes, G Rauw, et al.Biomedical Mass Spectrometry|May 1, 1982
A gas chromatographic mass spectrometric assay for plasma trifluoperazine concentrations following single dosesK K Midha, R M Roscoe, K Hall, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1990
The identification of urinary metabolites of doxepin in patientsY Z Shu, J W Hubbard, J K Cooper, et al.Biopharmaceutics & Drug Disposition|January 1, 1984
A bioequivalency study of two trifluoperazine tablet formulations using RIA and GC-MSK K Midha, E M Hawes, E D Korchinski, et al.Pageof 13